NO953989L - Nye polysykliske systemer og derivater derav, som neurotransmitter-frigivelsesforsökere som er anvendbare ved behandlingav erkjennelsessykdommer - Google Patents

Nye polysykliske systemer og derivater derav, som neurotransmitter-frigivelsesforsökere som er anvendbare ved behandlingav erkjennelsessykdommer

Info

Publication number
NO953989L
NO953989L NO953989A NO953989A NO953989L NO 953989 L NO953989 L NO 953989L NO 953989 A NO953989 A NO 953989A NO 953989 A NO953989 A NO 953989A NO 953989 L NO953989 L NO 953989L
Authority
NO
Norway
Prior art keywords
derivatives
treatment
neurotransmitter release
release assays
assays useful
Prior art date
Application number
NO953989A
Other languages
English (en)
Other versions
NO308745B1 (no
NO953989D0 (no
Inventor
Christopher Allan Teleha
Wendell Wilkie Wilkerson
Richard Alan Earl
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/216,881 external-priority patent/US5594001A/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO953989D0 publication Critical patent/NO953989D0/no
Publication of NO953989L publication Critical patent/NO953989L/no
Publication of NO308745B1 publication Critical patent/NO308745B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
NO953989A 1993-04-08 1995-10-06 Nye, polycykliske forbindelser samt preparater inneholdende disse NO308745B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4401293A 1993-04-08 1993-04-08
US08/216,881 US5594001A (en) 1993-04-08 1994-03-28 Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
PCT/US1994/003673 WO1994024131A1 (en) 1993-04-08 1994-04-04 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders

Publications (3)

Publication Number Publication Date
NO953989D0 NO953989D0 (no) 1995-10-06
NO953989L true NO953989L (no) 1995-12-07
NO308745B1 NO308745B1 (no) 2000-10-23

Family

ID=26721086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953989A NO308745B1 (no) 1993-04-08 1995-10-06 Nye, polycykliske forbindelser samt preparater inneholdende disse

Country Status (21)

Country Link
US (1) US5990132A (no)
EP (1) EP0693069A1 (no)
JP (1) JPH08509713A (no)
CN (2) CN1058495C (no)
AU (1) AU690906B2 (no)
BR (1) BR9405954A (no)
CA (1) CA2160112A1 (no)
CZ (1) CZ251995A3 (no)
FI (1) FI954775A (no)
HU (1) HUT74104A (no)
IL (1) IL109237A (no)
LV (1) LV11179B (no)
NO (1) NO308745B1 (no)
NZ (1) NZ265183A (no)
OA (1) OA10235A (no)
PL (1) PL178570B1 (no)
RO (1) RO115162B1 (no)
RU (1) RU2152944C1 (no)
SI (1) SI9420022A (no)
SK (1) SK124695A3 (no)
WO (1) WO1994024131A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750528A (en) * 1995-02-01 1998-05-12 The Dupont Merck Pharmaceutical Company Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease
US6262081B1 (en) 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
JP5581607B2 (ja) * 2008-06-05 2014-09-03 住友化学株式会社 高分子化合物及びそれを用いた有機トランジスタ
PT2909204T (pt) 2012-10-12 2019-03-21 Dana Farber Cancer Inst Inc Inibidores de gsk3 e métodos de utilização dos mesmos
KR101560061B1 (ko) * 2012-11-30 2015-10-15 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 전자 소자
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
WO2015027015A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imidazole-derived modulators of the glucocorticoid receptor
DK3102555T3 (da) 2014-02-05 2021-08-09 VM Oncology LLC Sammensætninger af forbindelser og anvendelser deraf
GB201417369D0 (en) * 2014-10-01 2014-11-12 Redx Pharma Ltd Compounds
MA46899A (fr) * 2016-11-07 2021-04-14 Univ Vanderbilt Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
CN110958882B (zh) 2017-04-05 2023-08-29 布罗德研究所股份有限公司 作为糖原合酶激酶3(gsk3)抑制剂的三环化合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052346A (no) * 1964-09-09
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
JPH06503095A (ja) * 1991-05-29 1994-04-07 ファイザー・インコーポレーテッド 三環式ポリヒドロキシ系のチロシンキナーゼ阻害薬
ES2100523T3 (es) * 1992-01-16 1997-06-16 Du Pont Merck Pharma Nuevos liberadores de neurotransmisores utiles para la potenciacion de las facultades cognoscitivas.
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
US5272269A (en) * 1992-01-16 1993-12-21 The Du Pont Merck Pharmaceutical Company Disubstituted polycyclic systems and preparative methods therefor
US5185447A (en) * 1992-01-29 1993-02-09 Du Pont Merck Pharmaceutical Company Polycyclic ketones and preparative methods therefor
US5359070A (en) * 1993-02-11 1994-10-25 The Du Pont Merck Pharmaceutical Company Unsymmetrical bis-imides as anticancer agents

Also Published As

Publication number Publication date
CN1122135A (zh) 1996-05-08
LV11179B (en) 1997-06-20
FI954775A0 (fi) 1995-10-06
NZ265183A (en) 1997-11-24
CN1058495C (zh) 2000-11-15
AU690906B2 (en) 1998-05-07
JPH08509713A (ja) 1996-10-15
PL310997A1 (en) 1996-01-22
HUT74104A (en) 1996-11-28
IL109237A0 (en) 1994-07-31
NO308745B1 (no) 2000-10-23
BR9405954A (pt) 1995-12-26
EP0693069A1 (en) 1996-01-24
WO1994024131A1 (en) 1994-10-27
NO953989D0 (no) 1995-10-06
LV11179A (lv) 1996-04-20
CZ251995A3 (en) 1996-01-17
OA10235A (en) 1997-10-07
CN1295072A (zh) 2001-05-16
FI954775A (fi) 1995-10-06
US5990132A (en) 1999-11-23
HU9502929D0 (en) 1995-11-28
SK124695A3 (en) 1996-06-05
RO115162B1 (ro) 1999-11-30
RU2152944C1 (ru) 2000-07-20
CA2160112A1 (en) 1994-10-27
IL109237A (en) 1998-02-08
AU6554994A (en) 1994-11-08
PL178570B1 (pl) 2000-05-31
SI9420022A (en) 1996-10-31

Similar Documents

Publication Publication Date Title
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
DE69433486D1 (de) Polarisator,polarisationsplatte und verfahren zu deren herstellung
DK0699104T3 (da) Fremgangsmåde til underkritisk tørring af aerogeler
NO985591L (no) FremgangsmÕte ved uttak av absorberende gjenstander
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
BR9806443B1 (pt) processo e aparelho para automaticamente compensar o volume de som.
NO953989L (no) Nye polysykliske systemer og derivater derav, som neurotransmitter-frigivelsesforsökere som er anvendbare ved behandlingav erkjennelsessykdommer
NO903594L (no) Fremgangsmaate for pulverisering av materialer, og anlegg til gjennomfoering av dette.
BR9200425A (pt) Processo para producao de uma pelicula contraida,pelicula contraida,laminados de pelicula contraida e uso da referida pelicula
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
EP0615148A3 (de) Verfahren und Vorrichtung zur Polarisation von Licht.
AU5301094A (en) Process for the recovery of valuable substances, in particular carotinoids from algae and installations suitable therefor
DE69021297D1 (de) Verschlussvorrichtung, welche auch als Blendeneinrichtung nutzbar ist.
BR9405735A (pt) Uso de 26,26,26,27,27,27-hexaflúor-1-alfa 25-dihidróxi colecalciferol para o tratamento de distúrbios do metabolismo do cálcio
ES1015823Y (es) Soporte para cerramientos temporales de seguridad en obras y similares.
ES1012513Y (es) Cejilla perfeccionada para guitarras y similares.
ES1024209Y (es) Dispositivo de seguridad para exposiciones de cuadros y similares.
ES1026698Y (es) Dispositivo de anclaje para focos empotrables y similares.
ES1028688Y (es) Dispositivo para el cierre de joyas.
ITRM930432A0 (it) Metodo per la deposizione di sistemi supramolecolari, di biomolecole ein generale, di molecole di grandi dimensioni e/o complessita' e/o labilita' senza loro frammentazione e/o perdita delle loro proprieta' strutturali e funzionali.
ES1024783Y (es) Dispositivo de bloqueo para la boca de la disketera en los aparatos ordenadores.
ES1025016Y (es) Dispositivo de seguridad para sujecion de colgantes en lamparas.
BR7301814U (pt) Alarme multi-uso para residências, lojas e escritórios
ES1023768Y (es) Dispositivo perfeccionadao para la formacion de estructuras espaciales.
ES1025868Y (es) Puerta perfeccionada para grandes luces.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001